This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
by Zacks Equity Research
Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions have been highlighted in this Investment Ideas article.
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
by Andrew Rocco
Is the next pandemic here. With health officials declaring Monkeypox a public health emergency, investors need to be watching Monkeypox-related stocks.
Applied DNA Sciences (APDN) Tops Q3 Earnings Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 173.44% and 16%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Axon Enterprise (AXON) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Axon (AXON) delivered earnings and revenue surprises of 13.21% and 5.70%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ball (BALL) Q2 Earnings Beat Estimates
by Zacks Equity Research
Ball (BALL) delivered earnings and revenue surprises of 1.37% and 3.52%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Applied DNA Sciences (APDN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).
Time to Play 5 Top-Ranked Stocks With Rising P/E?
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), Exagen (XGN), Health Catalyst (HCAT), CLEAR Secure (YOU) and Applied DNA Sciences (APDN).
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -15.43% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Clear Secure (YOU) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clear Secure (YOU) delivered earnings and revenue surprises of 64.71% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Automation (ROK) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Rockwell Automation (ROK) delivered earnings and revenue surprises of 16.28% and 4.22%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Allegion (ALLE) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Allegion (ALLE) delivered earnings and revenue surprises of 9.93% and 2.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Applied DNA Sciences (APDN) and Encore Wire (WIRE) have performed compared to their sector so far this year.
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 70.97% and 27.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
ADT (ADT) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
ADT (ADT) delivered earnings and revenue surprises of -30.43% and 2.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Proto Labs (PRLB) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Proto Labs (PRLB) delivered earnings and revenue surprises of 10% and 0.12%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Kennametal (KMT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Kennametal (KMT) delivered earnings and revenue surprises of -16.39% and 2.86%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Alarm.com Holdings (ALRM) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Alarm.com (ALRM) delivered earnings and revenue surprises of 36.67% and 1.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Clear Secure (YOU) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Clear Secure (YOU) delivered earnings and revenue surprises of 300% and 2.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Napco (NSSC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Napco (NSSC) delivered earnings and revenue surprises of 52.63% and 3.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
What Makes Applied DNA Sciences (APDN) a New Buy Stock
by Zacks Equity Research
Applied DNA Sciences (APDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RBC Bearings (RBC) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
RBC Bearings (RBC) delivered earnings and revenue surprises of 7.82% and 2.17%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Alta Equipment (ALTG) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Alta Equipment (ALTG) delivered earnings and revenue surprises of 16.67% and 5.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Alarm.com Holdings (ALRM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Alarm.com (ALRM) delivered earnings and revenue surprises of 10% and 2.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 8.33% and 19.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?